Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Valerie Y. H. van Weperen has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Marmar Vaseghi

    UCLA Electrophysiology Programs, Division of Cardiology, Department of Medicine, University of California, Los Angeles (UCLA), Los Angeles, USA

    3 shared publications
  • Shail Avasthi

    UCLA Electrophysiology Programs, Division of Cardiology, Department of Medicine, University of California, Los Angeles (UCLA), Los Angeles, USA

    2 shared publications
  • Albert Dunnink

    Department of Medical Physiology, Universitair Medisch Centrum Utrecht , Yalelaan 50, 3584 CM Utrecht , The Netherlands

    1 shared publication
  • Alexandre Bossu

    Department of Medical Physiology, Universitair Medisch Centrum Utrecht , Yalelaan 50, 3584 CM Utrecht , The Netherlands

    1 shared publication
  • Artin Khaky

    UCLA Cardiac Electrophysiology Programs, Division of Cardiology, Department of Medicine, University of California, Los Angeles, 100 Medical Plaza, Suite 660, Los Angeles, CA 90095, USA

    1 shared publication
  • Avram Oros

    Department of Medical Physiology, Universitair Medisch Centrum Utrecht , Yalelaan 50, 3584 CM Utrecht , The Netherlands

    1 shared publication

Latest Publications

  • Open Access

    Spinal nociceptive denervation impedes subsequent chronic autonomic remodeling after myocardial infarction in male swine

    by Valerie Y. H. van Weperen, Jonathan D. Hoang, Neil R. Jani, Shail Avasthi, Christopher A. Chan, Kuan Cao, Zulfiqar A. Lokhandwala, Maryam Emamimeybodi, Karim Atmani, Marmar Vaseghi

    After chronic myocardial infarction (MI), pathological autonomic remodeling, including vagal dysfunction and sympathoexcitation, predisposes to ventricular arrhythmias (VT/VF). However, what underlies this functional and structural remodeling remains unknown. We hypothesized that spinal nociceptive afferent signaling initiates and perpetuates these pathological autonomic changes. We employed cervicothoracic epidural resiniferatoxin (RTX) to ablate spinal nociceptive neurons in male pigs before MI, and assessed autonomic and electrophysiological function four-to-six weeks post-infarction. Compared to vehicle-treated infarcted animals, epidural RTX attenuated the loss of vagal tone and baroreflex sensitivity, reduced spinal cord inflammation, glial activation, and circulating stress and inflammatory markers, and stabilized electrophysiological parameters, lowering VT/VF inducibility. In a separate cohort, acute C7–T1 nociceptive afferent ablation after chronic MI acutely restored vagal function and decreased VT/VF inducibility. This study demonstrates that cervicothoracic spinal nociceptive afferents significantly contribute to MI-induced autonomic remodeling and VT/VF, providing novel insight into the mechanisms underlying sympathovagal imbalance after MI.


  • The brain–heart axis: effects of cardiovascular disease on the CNS and opportunities for central neuromodulation

    by Valerie Y. H. van Weperen, Marmar Vaseghi

    Bidirectional, multilevel communication between the heart and the brain is pivotal for the beat-to-beat regulation of cardiac function and the close titration of cardiac output to meet metabolic demand. Given this bidirectional communication, it is perhaps not surprising that cardiac pathologies lead to changes in the central and peripheral autonomic nervous system, which in turn lead to further progression of cardiovascular disease. Within the CNS, structural and functional changes have been reported in the setting of hypertension and heart failure in multiple autonomic regions and nuclei, including the spinal cord, brainstem, hypothalamus and higher centres, such as the amygdala and thalamus. These alterations enhance the excitability of sympathetic neuronal populations and diminish the excitability of neurons within the parasympathetic nuclei, resulting in sympathovagal imbalance. The primary drivers of these structural and functional changes appear to be a combination of increased angiotensin signalling (both central and peripheral), neuroinflammation, oxidative stress and glial activation. Targeting the CNS in the setting of cardiovascular disease presents an exciting avenue for the field of neuromodulation.


  • Open Access

    Tyrosine Hydroxylase-Expressing Neurons in the Vagal Ganglia: Characterization and Implications

    by Artin Khaky, Nicole Lee Yang, Valerie van Weperen, Shail Avasthi, Neil Jani, Marmar Vaseghi

    Background/Objectives: A combination of sympathoexcitation and parasympathetic withdrawal contributes to the occurrence of ventricular arrhythmias, sudden cardiac death, and progression of heart failure after myocardial injury. As a result, vagal nerve stimulation has been under investigation as a potential option to increase cardiac vagal tone, but the results of clinical trials have been mixed. Prior studies have suggested that the vagal ganglia and nerves may contain sympathetic neurons that express tyrosine hydroxylase (TH), which, if stimulated, could potentially mitigate the effects of vagal nerve stimulation. The goal of the current study was to better characterize these neurons. Methods: Immunohistochemical staining was performed to evaluate for the presence of TH-expressing neurons in the inferior vagal (nodose) ganglia from six pigs. Additional staining was performed for dopamine beta-hydroxylase (DBH), which is required for the production of norepinephrine (NE), to determine if these neurons are indeed sympathetic and capable of releasing NE. Analysis of stellate ganglia was also performed, given that these ganglia are known to provide sympathetic innervation to the heart and release NE in the myocardium. Results: While nearly all TH-expressing neurons in the stellate ganglia expressed DBH, confirming that they can produce or release NE, none of the TH-expressing neurons in the vagal ganglia expressed DBH, demonstrating that these are dopaminergic but not noradrenergic neurons. Conclusions: TH-expressing neurons in the vagal ganglia previously reported to be potentially “sympathetic” do not express DBH and are, therefore, not capable of synthesizing NE.


  • Open Access

    Chronically altered ventricular activation causes pro-arrhythmic cardiac electrical remodelling in the chronic AV block dog model

    by Valerie Y H van Weperen, Iris ter Horst, Albert Dunnink, Alexandre Bossu, Odette A Salden, Henriette D M Beekman, Avram Oros, Vincent Bourgonje, Thom Stams, Mathias Meine, et al.

    Altered ventricular activation (AVA) causes intraventricular mechanical dyssynchrony (MD) and impedes contraction, promoting pro-arrhythmic electrical remodelling in the chronic atrioventricular block (CAVB) dog. We aimed to study arrhythmogenic and electromechanical outcomes of different degrees of AVA. Following atrioventricular block, AVA was established through idioventricular rhythm (IVR; n = 29), right ventricular apex (RVA; n = 12) pacing or biventricular pacing [cardiac resynchronization therapy (CRT); n = 10]. After ≥3 weeks of bradycardic remodelling, Torsade de Pointes arrhythmia (TdP) inducibility, defined as ≥3 TdP/10 min, was tested with specific IKr-blocker dofetilide (25 μg/kg/5 min). Mechanical dyssynchrony was assessed by echocardiography as time-to-peak (TTP) of left ventricular (LV) free-wall minus septum (ΔTTP). Electrical intraventricular dyssynchrony was assessed as slope of regression line correlating intraventricular LV activation time (AT) and activation recovery interval (ARI). Under sinus rhythm, contraction occurred synchronous (ΔTTP: −8.6 ± 28.9 ms), and latest activated regions seemingly had slightly longer repolarization (AT–ARI slope: −0.4). Acute AV block increased MD in all groups, but following ≥3 weeks of remodelling IVR animals became significantly more TdP inducible (19/29 IVR vs. 5/12 RVA and 2/10 CRT, both P < 0.05 vs. IVR). After chronic AVA, intraventricular MD was lowest in CRT animals (ΔTTP: −8.5 ± 31.2 vs. 55.80 ± 20.0 and 82.7 ± 106.2 ms in CRT, IVR, and RVA, respectively, P < 0.05 RVA vs. CRT). Although dofetilide steepened negative AT–ARI slope in all groups, this heterogeneity in dofetilide-induced ARI prolongation seemed least pronounced in CRT animals (slope to −0.8, −3.2 and −4.5 in CRT, IVR and RVA, respectively). Severity of intraventricular MD affects the extent of electrical remodelling and pro-arrhythmic outcome in the CAVB dog model. After complete atrioventricular block, chronic atrioventricular block (CAVB) dogs were exposed to different extents of altered ventricular remodelling. Animals either remodelled under idioventricular rhythm (IVR), right ventricular apex (RVA) pacing or cardiac resynchronization therapy (CRT). After remodelling, mechanical dyssynchrony was assessed using echocardiography as difference in time-to-peak (TTP) of left ventricular (LV) free-wall and LV septum. Dofetilide was also administered to assess Torsade de Pointes arrhythmia (TdP) inducibility and dofetilide-induced activation recovery interval (ARI) prolongation. Severity of intraventricular mechanical dyssychrony was shown to affect the extent of electrical remodelling and pro-arrhythmic outcome in the CAVB dog model.